{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T18:58:36Z","timestamp":1785351516818,"version":"3.55.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"am","delay-in-days":350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.prp.2024.155348","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T15:28:11Z","timestamp":1715614091000},"page":"155348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma"],"prefix":"10.1016","volume":"258","author":[{"given":"Yuko","family":"Hino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Kohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naonori","family":"Kawakubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Fukuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shibui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155348_bib1","doi-asserted-by":"crossref","unstructured":"E. Hiyama, T. Hishiki, K. Watanabe, Kohmei Ida, Y. Ueda, S. Kurihara, M. Yano, K. Hoshino, A. Yokoi, Y. Takama, Y. Nogami, T. Taguchi, M. Mori, Kentaro Kihira, Osamu Miyazaki, H. Fuji, S. Honda, T. Iehara, T. Kazama, J. Fujimura, Yukichi Tanaka, Takeshi Inoue, Tatsuro Tajiri, Satoshi Kondo, Takaharu Oue, K. Yoshimura, Outcome and Late Complications of Hepatoblastomas Treated Using the Japanese Study Group for Pediatric Liver Tumor 2 Protocol, 2020. https:\/\/doi.org\/10.","DOI":"10.1200\/JCO.19.01067"},{"key":"10.1016\/j.prp.2024.155348_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1053\/j.sempedsurg.2016.09.002","article-title":"Malignant tumors of the liver in children","volume":"25","author":"Aronson","year":"2016","journal-title":"Semin Pedia Surg."},{"key":"10.1016\/j.prp.2024.155348_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkz007","article-title":"Trends in international incidence of pediatric cancers in children under 5 years of age: 1988\u20132012","volume":"3","author":"Hubbard","year":"2019","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.prp.2024.155348_bib4","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(18)30895-7","article-title":"Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children\u2019s Oncology Group, multicentre, phase 3 trial","volume":"20","author":"Katzenstein","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib5","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1056\/NEJMoa1801109","article-title":"Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss","volume":"378","author":"Brock","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2024.155348_bib6","series-title":"WHO Classification of Tumours\u22c55th Edition. Digestive System Tumours","first-page":"240","article-title":"Hepatoblastoma. The WHO Classification of Tumours Editorial Board Eds","author":"Saxena","year":"2019"},{"key":"10.1016\/j.prp.2024.155348_bib7","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5858\/2007-131-520-PFTEOS","article-title":"CAP Laboratory Improvement Programs Protocol for the Examination of Specimens From Pediatric Patients With Hepatoblastoma","volume":"131","author":"Finegold","year":"2007","journal-title":"Arch. Pathol. Lab Med"},{"key":"10.1016\/j.prp.2024.155348_bib8","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/modpathol.2013.80","article-title":"Towards an international pediatric liver tumor consensus classification: Proceedings of the Los Angeles COG liver tumors symposium","author":"L\u00f3pez-Terrada","year":"2014","journal-title":": Mod. Pathol."},{"key":"10.1016\/j.prp.2024.155348_bib9","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/(SICI)1097-0215(19971219)74:6<593::AID-IJC6>3.0.CO;2-P","article-title":"Prognostic factors and staging systems in childhood hepatoblastoma","volume":"74","author":"Von Schweinitz","year":"1997","journal-title":"Int J. Cancer"},{"key":"10.1016\/j.prp.2024.155348_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1158\/1541-7786.MCR-09-0432","article-title":"FOXM1 confers acquired cisplatin resistance in breast cancer cells","volume":"8","author":"Kwok","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.prp.2024.155348_bib11","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1002\/cncr.28354","article-title":"Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas","volume":"119","author":"Hwang","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2024.155348_bib12","doi-asserted-by":"crossref","first-page":"6791","DOI":"10.1158\/1078-0432.CCR-11-1214","article-title":"Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients","volume":"17","author":"Priller","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.prp.2024.155348_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251079","article-title":"CHD4 regulates platinum sensitivity through MDR1 expression in ovarian cancer: A potential role of CHD4 inhibition as a combination therapy with platinum agents","volume":"16","author":"Oyama","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2024.155348_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2024.155348_bib15","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S1470-2045(13)70272-9","article-title":"Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): A prospective, single-arm, feasibility study","volume":"14","author":"Zsiros","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.1993.11.1.96","article-title":"Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study","volume":"11","author":"Douglass","year":"1993","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib17","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.jpedsurg.2016.09.038","article-title":"Resectability and tumor response after preoperative chemotherapy in hepatoblastoma treated by the Japanese Study Group for Pediatric Liver Tumor (JPLT)-2 protocol","volume":"51","author":"Hiyama","year":"2016","journal-title":"J. Pedia Surg."},{"key":"10.1016\/j.prp.2024.155348_bib18","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/hepr.13479","article-title":"Hypermethylation of CSF3R is a novel cisplatin resistance marker and predictor of response to postoperative chemotherapy in hepatoblastoma","volume":"50","author":"Fujiyoshi","year":"2020","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.prp.2024.155348_bib19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbagrm.2011.09.004","article-title":"FOXM1: From cancer initiation to progression and treatment","volume":"1819","author":"Koo","year":"2012","journal-title":"Biochim Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.prp.2024.155348_bib20","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5483\/BMBRep.2019.52.3.249","article-title":"Downregulation of FoxM1 sensitizes nasopharyngeal carcinoma cells to cisplatin via inhibition of MRN-ATM-mediated DNA repair","volume":"52","author":"Li","year":"2019","journal-title":"BMB Rep."},{"key":"10.1016\/j.prp.2024.155348_bib21","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s00432-020-03438-w","article-title":"The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor","volume":"147","author":"Shibui","year":"2021","journal-title":"J. Cancer Res Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib22","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1007\/s13277-015-4351-9","article-title":"FOXM1 expression in rhabdomyosarcoma: a novel prognostic factor and therapeutic target","volume":"37","author":"Kuda","year":"2016","journal-title":"Tumor Biol."},{"key":"10.1016\/j.prp.2024.155348_bib23","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1470-2045(16)30598-8","article-title":"Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children\u2019s Hepatic tumors International Collaboration","volume":"18","author":"Meyers","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib24","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1515\/cclm-2018-0803","article-title":"Serum \u03b1-fetoprotein in pediatric oncology: Not a children\u2019s tale","volume":"57","author":"Ferraro","year":"2019","journal-title":"Clin. Chem. Lab Med"},{"key":"10.1016\/j.prp.2024.155348_bib25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ejca.2005.02.004","article-title":"Guidelines for surgical treatment of hepatoblastoma in the modern era - Recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL)","volume":"41","author":"Czauderna","year":"2005","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.prp.2024.155348_bib26","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1007\/s10147-018-1285-4","article-title":"Rapid decrease of serum alpha-fetoprotein and tumor volume predicts outcome in children with hepatoblastoma treated with neoadjuvant chemotherapy","volume":"23","author":"Nguyen","year":"2018","journal-title":"Int J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib27","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00247-014-3000-6","article-title":"Relapse surveillance in AFP-positive hepatoblastoma: re-evaluating the role of imaging","volume":"44","author":"Rojas","year":"2014","journal-title":"Pedia Radio."},{"key":"10.1016\/j.prp.2024.155348_bib28","article-title":"Prognostic factors for event-free survival in liver transplantation for hepatoblastoma: A single-center experience","volume":"23","author":"Lauferman","year":"2019","journal-title":"Pedia Transpl."},{"key":"10.1016\/j.prp.2024.155348_bib29","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4149\/neo_2015_008","article-title":"FOXM1 overexpression is associated with cisplatin resistance in non-small cell lung cancer and mediates sensitivity to cisplatin in A549 cells via the JNK\/mitochondrial pathway","volume":"62","author":"Liu","year":"2015","journal-title":"Neoplasma"},{"key":"10.1016\/j.prp.2024.155348_bib30","doi-asserted-by":"crossref","first-page":"482","DOI":"10.7150\/jca.50255","article-title":"Targeting the CtBP1-FOXM1 transcriptional complex with small molecules to overcome MDR1-mediated chemoresistance in osteosarcoma cancer stem cells","volume":"12","author":"Chen","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.prp.2024.155348_bib31","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/cncr.30591","article-title":"Upfront window vincristine\/irinotecan treatment of high-risk hepatoblastoma: A report from the Children\u2019s Oncology Group AHEP0731 study committee","volume":"123","author":"Katzenstein","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2024.155348_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pbc.24038","article-title":"Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma","volume":"59","author":"Venkatramani","year":"2012","journal-title":"Pedia Blood Cancer"},{"key":"10.1016\/j.prp.2024.155348_bib33","doi-asserted-by":"crossref","first-page":"326","DOI":"10.21037\/jgo.2018.01.08","article-title":"Histological and immunohistochemical study of hepatoblastoma: Correlation with tumour behaviour and survival","volume":"9","author":"Kiruthiga","year":"2018","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib34","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/j.ejso.2014.07.033","article-title":"Predictors of survival after resection of children with hepatoblastoma: A single Asian center experience","volume":"40","author":"Qiao","year":"2014","journal-title":"Eur. J. Surg. Oncol."},{"key":"10.1016\/j.prp.2024.155348_bib35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1101\/gad.256214.114","article-title":"Resistance to therapy in BRCA2 mutant cells due to loss of the nucleosome remodeling factor CHD4","volume":"29","author":"Guillemette","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.prp.2024.155348_bib36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nature18325","article-title":"Replication fork stability confers chemoresistance in BRCA-deficient cells","volume":"535","author":"Chaudhuri","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.prp.2024.155348_bib37","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.7150\/ijbs.56976","article-title":"Chd4 as an important mediator in regulating the malignant behaviors of colorectal cancer","volume":"17","author":"Chang","year":"2021","journal-title":"Int J. Biol. Sci."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824002590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824002590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T17:39:01Z","timestamp":1716658741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824002590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":37,"alternative-id":["S0344033824002590"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155348","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"FOXM1 and CHD4 expression is associated with chemoresistance in hepatoblastoma","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155348"}}